
Hologic Inc
NASDAQ:HOLX

Operating Margin
Hologic Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
US |
![]() |
Hologic Inc
NASDAQ:HOLX
|
14.7B USD |
24%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
218.9B USD |
18%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
159.4B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
153.2B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
118B USD |
20%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
52.3B USD |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
28%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.7B USD |
29%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.1B USD |
32%
|
Hologic Inc
Glance View
Hologic Inc., headquartered in Marlborough, Massachusetts, crafts a narrative deeply intertwined with the vital mission of women's health. Established in 1985, the company has grown into a prominent player in the medical device and diagnostics realm. Hologic’s success is anchored in its core business sectors: Breast & Skeletal Health, Diagnostic Solutions, GYN Surgical, and Medical Aesthetics. The cornerstone of this expansive operation is innovation, driving the development of advanced technologies like 3D mammography systems that revolutionize breast cancer detection. This strategic focus on high-value diagnostics and medical equipment allows Hologic to capture significant market share, ensuring a steady revenue stream from both capital equipment sales and ongoing service and maintenance contracts. Beyond its robust presence in imaging and diagnostics, Hologic amplifies its influence through a comprehensive array of solutions for early stage disease detection and treatment. Their Diagnostic Solutions arm, particularly strengthened by molecular diagnostic tests, is a response to the increasing global demand for rapid and accurate testing solutions—a need only intensified by recent global health challenges. These products not only provide critical tools for healthcare professionals but also secure recurring income for Hologic through the sale of consumables and tests. By embedding itself in the cycles of medical advancements and enhancing the standard of care, Hologic generates sustainable growth and remains a crucial ally in both public and specialized health sectors. The company’s blend of technology-driven products and strategic agility enables it to navigate dynamic markets while maintaining a resolute focus on improving health outcomes around the world.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Hologic Inc's most recent financial statements, the company has Operating Margin of 24.4%.